FDA NDC Directory · JSON-LD · Markdown

Irbesartan

NDC 65162-286 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAmneal Pharmaceuticals LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA204740
Dosage form / routeTABLET · ORAL
Active ingredientsIRBESARTAN (300 mg/1)
Marketing started20180417
Package count4

External sources

Source: openFDA. Public-domain (CC0).